TCR2 Therapeutics Inc (NASDAQ:TCRR)
| 1.46 Delayed Data As of 3:57pm ET |  +0.07 / +5.04%Today’s Change | 0.82 Today|||52-Week Range 3.88 | +46.18% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Operating Activities | Net Income / Starting Line | -9.9M | -13.1M | -24.3M | -- | |
| Depreciation | 220.0K | 298.0K | 419.0K | -- | ||
| Total Other Cash Flow | 93.0K | 408.0K | 1.9M | -- | ||
| Funds From Operations | -9.6M | -12.4M | -22.0M | -- | ||
| Funds From/For Other Operating Expenses | -222.0K | -329.0K | -3.2M | -- | ||
| Net Cash Flow - Operating Activities | -9.4M | -12.0M | -18.8M | -- | ||
| Investing | Increase In Investments | -8.4M | -6.8M | -97.8M | -- | |
| Decrease In Investments | 0.00 | 14.8M | 22.5M | -- | ||
| Capital Expenditures | -869.0K | -388.0K | -1.0M | -- | ||
| Net Cash Flow Investing | -9.2M | 7.7M | -76.3M | -- | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Proceeds Stock Sale | 22.5M | 16.2M | 123.0M | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | -- | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Cash Flow - Financing | 22.5M | 16.2M | 123.0M | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 3.9M | 11.8M | 27.9M | -- | ||
